Stents clinical experience

I 9 SousaJE, Abizaid AAC, Abizaid ACLS, et al. First human experience with sirolimus coated BX Velocity stent clinical, angiographic and ultrasound late results [abstr]. Circulation 2000 102(1 8) ll-81 5,... [Pg.261]

Clinical experience with the CYPHER sirolimus-eluting stent... [Pg.272]

Clinical experience with nonpolymeric paclitaxel drug-eluting stent systems... [Pg.274]

Grube E, Buellesfeld L, Paclitaxel-eluting stents current clinical experience, AmJ Cardiovasc Drugs 2004 4(6/355-360. [Pg.278]

Henry M, Amor M, Henry I, et al. Carotid stenting with cerebral protection first clinical experience using the PercuSurge GuardWire system. J Endovasc Surg 1999 6 321-331. [Pg.565]

Peluso JP, van Rooij WJ, Sluzewski M, Beute GN. A new self-expandable nitinol stent for the treatment of wide-neck aneurysms initial clinical experience. AJNR Am J Neuroradiol. 2008 29 1405-1408... [Pg.290]

Wanke I, Doerfler A, Schoch B, Stolke D, Forsting M (2003) Treatment of wide-necked intracranial aneurysms with a self-expanding stent system initial clinical experience. AJNR Am J Neuroradiol 24 1192-1199 Wanke I, Doerfler A, Goericke S, Gizewski ER, Sandalcioglu... [Pg.282]

Dumon (Dumon 1990) introduced another silicone tube stent, which is available in different lengths and diameters and comes with external protrusions for better fixation. The Dumon stent (Novatech, Aub-agne, France) has become the most commonly used silicone stent. This stent requires a rigid bronchoscope and a special introducer system for placement. Because so much clinical experience (Cavaliere et al. 1996 Dumon et al. 1996) has been gained with this stent it has become the gold standard for most bronchoscopists. Therefore, newer stent designs must be measured in comparison to this stent. [Pg.248]

Kwok OH, Chow WH, Law TC, et al. First human experience with angiopeptin-eluting stent a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Catheter Cardiovasc Interv2005 66(4) 54l-546. Nakamura M, Wada M, Hara H, et al. Angiographic and clinical outcomes of a pharmacokinetic study of sirolimus-eluting stents lesson from restenosis cases. Circ J 2005 69(10) ... [Pg.265]

This study represents the first human experience with 1713-estradiol-eluting stents for the prevention of restenosis. The clinical outcome that was maintained up to one-year follow-up suggests that the use of l7(3-estradiol-eluting, PC-coated stents is safe and feasible, with a low incidence of restenosis and without associated local or systemic toxicity. The angiographic and IVUS follow-up results at six months demonstrated a low amount of intimal hyperplasia and late-loss, which compared favorably with previous studies testing the same PC-coated... [Pg.350]

Final choice of the stent should be done according to the clinical situation and the experience of the interventionist. In the case of non-malignant disease a metallic stent should be chosen with hesitation, especially if there is an inflammatory process that predisposes to induction of granulation tissue. In a palliative situation, metallic stents can... [Pg.251]

Strecker EP, Liermann D, Barth KH et al. (1990) Expandable tubular stents for treatment of arterial occlusive diseases experimental and clinical results. Radiology 175 87-102 Tan BS, Watkinson AF, Dussek JE, Adam AN (1996) Metallic endoprostheses for malignant tracheobronchial obstruction initial experience. Cardiovasc Intervent Radiol 19 91-96... [Pg.270]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...